Trials / Completed
CompletedNCT03725228
Lidocaine Compared to Magnesium Sulfate to Prolong Spinal Anesthesia: Non-inferiority Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Brasilia University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the addition of continuous infusion of lidocaine or continuous infusion of magnesium sufate in the duration of spinal anesthesia.
Detailed description
Both lidocaine and magnesium sulfate have been shown to prolong spinal anesthesia. The number of studies using magnesium sulfate to improve spinal anesthesia is greater than the number of studies using lidocaine, and methodology varies significantly between studies. Adverse effects of lidocaine are different from magnesium sulfate's. Lidocaine has a wider therapeutic interval with fewer side effects, including: Drowsiness, Feeling Anxious, Feeling Cold, Nervous, Numbness And Tingling, Signs And Symptoms At Injection Site, Twitching. Magnesium sulfate's side effects include: heart disturbances, breathing difficulties, poor reflexes, confusion, weakness, flushing (warmth, redness, or tingly feeling), sweating, lowered blood pressure, feeling like you might pass out, anxiety, cold feeling, extreme drowsiness, muscle tightness or contraction, or headache.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium Sulfate | Magnesium Sulfate 15mg/kg/h |
| DRUG | Lidocaine | Lidocaine 1,5mg/kg/h |
Timeline
- Start date
- 2018-11-07
- Primary completion
- 2019-02-01
- Completion
- 2019-04-01
- First posted
- 2018-10-30
- Last updated
- 2020-02-27
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03725228. Inclusion in this directory is not an endorsement.